Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
NBY logo

NBY

AMX
NovaBay Pharmaceuticals Inc.
HealthcareBiotechnology
Watchlists:
Last updated: Friday 11th July 2025
0.65
+0.00 (0.05%)
Prev Close:0.6494
Open:0.61
Bid:0.6138
Ask:0.6497
52 Week Range
0.36
2.45
Volume:35,899
Mkt Cap:4 M
Price Target
$0.75
+15.4%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Scores

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

NBY - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Accrued Preferred Stock Dividends735000.0800000.0
Depletion6 M
Depreciation And Amortization904000.02 M120000.059000.051000.065000.0-266000.0-95000.0-114000.0-164000.0
Development Expense7 M
Fees-380000.0
Gain On Sale Of Business-865000.0
Gain On Sale Of PPE-25000.0-68000.0-1000.0-3000.0-1000.0219000.01000.0
Gain On Sale Of Security561000.03000.0424000.0
General And Administrative Expense7 M5 M7 M7 M6 M5 M6 M9 M7 M8 M
Gross Profit Margin (profit Margin After CGS)6 M6 M8 M7 M6 M5 M11 M15 M9 M3 M
Impairment Of Capital Assets1000000.07 M-70000.0
Interest Expense Non Operating904000.018000.0
Marketing Expense6 M
Misc Other Special Charges-449000.0-97000.05 M3 M-5 M-705000.01 M-89000.0-2 M2 M
Net Income (loss)-7 M-10 M-11 M-7 M-11 M-10 M-7 M-7 M-13 M-19 M
Net Income Common Stockholders-9 M-17 M-16 M-7 M-11 M-10 M-7 M-7 M-13 M-19 M
Net Income Continuous Operations-7 M-10 M-11 M-7 M-11 M-10 M-7 M-7 M-13 M-19 M
Net Income From Other Gains Losses-2 M
Net Non Operating Interest Income Expense-18000.0
Normalized Income-6 M-5 M
Operating Income-6 M-4 M-14 M-9 M-6 M-9 M-8 M-7 M-11 M-21 M
Operating Income Before Depreciation (EBITDA)-6 M-8 M-7 M-9 M-6 M-9 M-6 M-7 M-13 M-19 M
Operating Expense12 M10 M15 M15 M12 M14 M19 M23 M20 M-24 M
Other Gand A7 M5 M7 M7 M6 M5 M6 M9 M7 M8 M
Other Impairment Of Capital Assets2 M100000.03 M12000.010000.0125000.00.0
Other Operating Expenses400000.0403000.0525000.0418000.0826000.01 M-359000.0-17000.0-76000.0
Other Write Down7 M
Otherunder Preferred Stock Dividend735000.0800000.0
Preferred Stock Dividends735000.0800000.0
Promotion And Advertising700000.01 M2 M3 M2 M500000.0
Rent And Landing Fees-505000.0-389000.0-938000.08 M
Research Expense42000.034000.0174000.044000.0285000.0184000.0259000.0410000.01 M6 M
Salaries And Wages148000.0291000.0-1 M
Selling And Marketing Expense5 M5 M8 M8 M6 M9 M13 M14 M12 M11 M
Selling Expense1 M11 M
Total Income Available For Interest Expense (EBIT)-6 M-10 M-8 M-9 M-6 M-10 M-7 M-7 M-13 M-19 M
Total Revenues10 M10 M14 M10 M10 M7 M13 M18 M12 M4 M
Total Expenses16 M15 M22 M19 M16 M16 M20 M26 M23 M-26 M
Total Revenue10 M10 M14 M10 M10 M7 M13 M18 M12 M4 M
Amord904000.02 M2 M5 M
Avgshs3 M120428.02 M1 M1 M618314.0483457.0437828.0268800.079542.0
Avgshsdt3 M120428.02 M1 M1 M618314.0487371.0437828.0268800.079542.0
Basiceps-2.53-138.6-10.1-5.25-10.85-16.8-13.65-16.8-49.0
Basicepscont-2.53-138.6-10.1-5.25-10.85-16.8-13.65-16.8-49.0
Cor3 M4 M7 M4 M4 M2 M2 M3 M2 M-1 M
Depamor40000.051000.0120000.059000.051000.065000.0-266000.0-95000.0-114000.0-164000.0
Dileps-2.53-138.6-10.1-5.25-10.85-16.8-16.1-16.8-49.0-238.7
Dilepscont-10.85-16.8-16.1-16.8-49.0
Netincdisc-7 M-10 M-11 M-7 M-11 M-10 M-7 M-7 M-13 M-19 M
Othincexp1 M97000.0-3 M-3 M5 M281000.0-1 M89000.02 M-2 M
Pretaxinc-9 M-13 M-11 M-6 M-11 M-10 M-7 M-7 M-13 M-19 M
Resdev42000.07 M174000.044000.0285000.0184000.0259000.0410000.01 M6 M
Sga12 M10 M15 M15 M12 M14 M19 M22 M19 M19 M
Shsout6 M859947.058155.02 M2 M2 M2 M2 M2 M2 M
Specincchg-1000000.0-7 M70000.0
Taxprov5000.06000.04000.03000.02000.02000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader